CV Sciences, Inc. Applauds California Assembly Support of Hemp-derived CBD products through Unanimous Passing of AB 228

May 22, 2019

CV Sciences’ PlusCBD Oil™ Used in First Study Examining Clinical Benefit of CBD for Patients with PTSD

May 14, 2019

CV Sciences, Inc. Reports First Quarter 2019 Financial Results

May 8, 2019

CV Sciences, Inc. to Present at Upcoming Investor Conferences

May 7, 2019

CV Sciences, Inc. to Announce First Quarter 2019 Results on May 8, 2019

Apr 30, 2019

CV Sciences, Inc. Appoints Deloitte & Touche LLP as Auditor

Apr 15, 2019

CV Sciences, Inc. Announces Distribution Expansion Into Food, Drug and Mass Channels

Apr 10, 2019

CV Sciences, Inc. Appoints Joerg Grasser as New Chief Financial Officer

Mar 21, 2019

CV Sciences, Inc. Reports Fiscal Year-End 2018 Financial Results

Mar 12, 2019

CV Sciences, Inc. Appoints Dr. Douglas MacKay as Senior Vice President of Scientific and Regulatory Affairs

Mar 1, 2019